Premium
DiaMedica Therapeutics Inc (DMAC)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials fo... DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.44 | -7.23684210526 | 6.08 | 6.4411 | 5.54 | 165483 | 5.82328542 | CS |
| 4 | -0.86 | -13.2307692308 | 6.5 | 6.63 | 5.501 | 158130 | 5.99194794 | CS |
| 12 | -1.68 | -22.9508196721 | 7.32 | 7.69 | 5.501 | 187702 | 6.43952335 | CS |
| 26 | -3.02 | -34.8729792148 | 8.66 | 10.4195 | 5.501 | 235463 | 7.66573646 | CS |
| 52 | 1.43 | 33.9667458432 | 4.21 | 10.4195 | 3.475 | 309778 | 6.60285664 | CS |
| 156 | 3.04 | 116.923076923 | 2.6 | 10.4195 | 1.9382 | 155621 | 5.69009779 | CS |
| 260 | -1.77 | -23.8866396761 | 7.41 | 10.4195 | 1.12 | 142510 | 4.86001767 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
